Indicated for the treatment of HR+, HER2- advanced or metastatic breast cancer in women: In combination with an aromatase inhibitor (e.g., Letrozole) as initial endocrine-based therapy. In combination with Fulvestrant in women with disease progression following endocrine therapy.

Dosage and administration

Standard Dosage: 125 mg once daily. ⚠️ THE "21/7" CYCLE RULE: 📅 Days 1–21: Take one capsule daily. 🛑 Days 22–28: Take NO medication (7-day break). This allows your white blood cell count to recover. Repeat the cycle. 🍔 Food Requirement: Take this capsule WITH FOOD. Food significantly increases the absorption of the drug.

Pregnancy and breastfeeding. Severe neutropenia (low white blood cell count). Hypersensitivity to Palbociclib. Avoid grapefruit and grapefruit juice.

Regular blood tests (CBC) are mandatory: 📉 Neutropenia: Low count of neutrophils (white blood cells) is extremely common. It is usually reversible during the 7-day break. Fatigue: Feeling tired or weak. Infections: Due to lowered immunity. Hair thinning (Alopecia).

Palbocib — Palbociclib 125 mg, 21 pcs, Aprazer

100% original product

Active ingredient

Palbociclib

Manufacturer

Aprazer

Dosage

125 mg

Dosage form Capsules

Capsules per pack 21

Palbocib (Palbociclib) 125 mg

Name: Palbocib
Brand: Aprazer
SKU: PROD-92
Price: 4023 UAH
Availability: InStock

4023₴ ~~4694₴~~ -14%

Analogues

Palbocent 125 Palbocib Palbotiz Palboxen Palnat 125 Piclib Reampla 125

Lab test

Palbociclib confirmed by an independent laboratory

Palbocib 125 mg capsules were tested by liquid chromatography–mass spectrometry (LC-MS). The laboratory’s conclusion: the capsule contains the active substance palbociclib. The test confirms the substance is present; the amount per capsule (in mg) was not measured separately.

Otava laboratory, Kyiv · report No. 3050/2026 · 30.06.2026

Open report Download PDF

More about the test

Active ingredient

Palbociclib

Manufacturer

Aprazer

Dosage

125 mg

Dosage form Capsules

Capsules per pack 21

Palbocib-125 (Palbociclib 125 mg) is a CDK4/6 inhibitor, a class of drugs that has revolutionized the treatment of metastatic breast cancer.

Manufacturer: Aprazer (India). A generic equivalent to Ibrance.

Mechanism ("The Cellular Brake"):

Cancer cells often have overactive CDK4/6 proteins that drive them to divide uncontrollably. Palbociclib blocks these proteins, effectively stopping the cell division cycle. It works synergistically with hormonal therapy to delay disease progression significantly.

✅ Key Benefit: Offers a chemotherapy-free option that maintains quality of life for longer.

Indicated for the treatment of HR+, HER2- advanced or metastatic breast cancer in women:

In combination with an aromatase inhibitor (e.g., Letrozole) as initial endocrine-based therapy.
In combination with Fulvestrant in women with disease progression following endocrine therapy.

Standard Dosage: 125 mg once daily.

⚠️ THE "21/7" CYCLE RULE:

📅 Days 1–21: Take one capsule daily.
🛑 Days 22–28: Take NO medication (7-day break). This allows your white blood cell count to recover.
Repeat the cycle.

🍔 Food Requirement: Take this capsule WITH FOOD. Food significantly increases the absorption of the drug.

Pregnancy and breastfeeding.
Severe neutropenia (low white blood cell count).
Hypersensitivity to Palbociclib.
Avoid grapefruit and grapefruit juice.

Regular blood tests (CBC) are mandatory:

📉 Neutropenia: Low count of neutrophils (white blood cells) is extremely common. It is usually reversible during the 7-day break.
Fatigue: Feeling tired or weak.
Infections: Due to lowered immunity.
Hair thinning (Alopecia).

100% original product

Delivery across Ukraine

Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 04.03.2026